Rhoen Klinikum AG
XETRA:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
XETRA:RHK
Watchlist
Price: 13.9 EUR 0.72% Market Closed
Market Cap: 930.4m EUR
Have any thoughts about
Rhoen Klinikum AG?
Write Note
Section:
 

Relative Value

The Relative Value of one RHK stock under the Base Case scenario is 17.78 EUR. Compared to the current market price of 13.9 EUR, Rhoen Klinikum AG is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RHK Relative Value
Base Case
17.78 EUR
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
79
vs Industry
78
Median 3Y
0.6
Median 5Y
0.7
Industry
2.3
Forward
0.6
More Details
20.7
P/E
P/E
Price to Earnings
20.7
vs History
87
vs Industry
29
Median 3Y
30.3
Median 5Y
34
Industry
23.1
Forward
23.7
More Details
6.5
P/OCF
P/OCF
Price to OCF
6.5
vs History
92
vs Industry
41
Median 3Y
10.6
Median 5Y
10.3
Industry
14.2
More Details
16.5
P/FCFE
P/FCFE
Price to FCFE
16.5
vs History
44
vs Industry
21
Median 3Y
13.9
Median 5Y
14.5
Industry
20.1
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
79
vs Industry
73
Median 3Y
0.7
Median 5Y
0.9
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
88
vs Industry
85
Median 3Y
0.4
Median 5Y
0.6
Industry
2.4
Forward
0.3
More Details
0.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.5
vs History
88
vs Industry
85
Median 3Y
0.6
Median 5Y
0.8
Industry
5
More Details
4.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.5
vs History
88
vs Industry
48
Median 3Y
5.3
Median 5Y
7.5
Industry
12.7
Forward
4.3
More Details
10.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.7
vs History
88
vs Industry
39
Median 3Y
16.7
Median 5Y
21
Industry
17.1
Forward
10.5
More Details
3.4
EV/OCF
EV/OCF
Enterprise Value to OCF
3.4
vs History
93
vs Industry
50
Median 3Y
8.5
Median 5Y
8.1
Industry
14
More Details
7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7
vs History
60
vs Industry
34
Median 3Y
6.8
Median 5Y
10.5
Industry
18
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
87
vs Industry
81
Median 3Y
0.5
Median 5Y
0.6
Industry
1.9
More Details

Multiples Across Competitors

RHK Competitors Multiples
Rhoen Klinikum AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Rhoen Klinikum AG
XETRA:RHK
930.4m EUR 0.6 20.7 4.5 10.7
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27 27
MY
IHH Healthcare Bhd
KLSE:IHH
63.8B MYR 2.7 23.9 12.9 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.6 106.6 73.9 88.1
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.5
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.2 100.7 42 57.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.7 10.7

See Also

Summary
RHK intrinsic value, competitors valuation, and company profile.
DCF Valuation
RHK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RHK stock valuation using valuation multiples.
Wall Street Estimates
RHK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RHK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.